IE800693L - Cancer diagnostic test - Google Patents
Cancer diagnostic testInfo
- Publication number
- IE800693L IE800693L IE800693A IE69380A IE800693L IE 800693 L IE800693 L IE 800693L IE 800693 A IE800693 A IE 800693A IE 69380 A IE69380 A IE 69380A IE 800693 L IE800693 L IE 800693L
- Authority
- IE
- Ireland
- Prior art keywords
- serum
- cancer
- diagnostic test
- cancer diagnostic
- dna
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57411—Specifically defined cancers of cervix
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
- G01N2333/4704—Inhibitors; Supressors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/50—Fibroblast growth factors [FGF]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Plant Substances (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Sink And Installation For Waste Water (AREA)
- Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Inhibitor protein X in its substantially pure form having the following characterising properties: (i) it is a protein isolatable from human blood serum; (ii) it has a molecular weight of about 64,000 daltons and a Pl of 5.9; (iii) it inhibits bleomycin-induced degradation of PM-2 DNA by binding to the DNA; and (iv) it is found in lower concentrations in the serum of human beings having cancer than in the serum of cancer-free human beings. h
[GB2047712A]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2873279A | 1979-04-10 | 1979-04-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
IE800693L true IE800693L (en) | 1980-10-10 |
IE49981B1 IE49981B1 (en) | 1986-01-22 |
Family
ID=21845111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE693/80A IE49981B1 (en) | 1979-04-10 | 1980-04-03 | A human serum dna-binding protein and diagnostic test method |
Country Status (24)
Country | Link |
---|---|
JP (1) | JPS55143441A (en) |
KR (1) | KR830002502A (en) |
AR (1) | AR222700A1 (en) |
AT (1) | AT365343B (en) |
AU (1) | AU536522B2 (en) |
BE (1) | BE882669A (en) |
CH (1) | CH644453A5 (en) |
DE (1) | DE3013837A1 (en) |
DK (1) | DK149980A (en) |
ES (1) | ES8103380A1 (en) |
FI (1) | FI801078A (en) |
FR (1) | FR2454099A1 (en) |
GB (1) | GB2047712B (en) |
GR (1) | GR67692B (en) |
HU (1) | HU183122B (en) |
IE (1) | IE49981B1 (en) |
IL (1) | IL59772A (en) |
IT (1) | IT1143135B (en) |
LU (1) | LU82345A1 (en) |
NL (1) | NL8002094A (en) |
NO (1) | NO801018L (en) |
PH (1) | PH15637A (en) |
SE (1) | SE8002602L (en) |
ZA (1) | ZA802141B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3524644A1 (en) * | 1985-07-10 | 1987-01-15 | Heyl Chem Pharm | UNDULIN AND ITS PEPTIDE FRAGMENTS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
-
1980
- 1980-03-28 PH PH23825A patent/PH15637A/en unknown
- 1980-04-03 SE SE8002602A patent/SE8002602L/en not_active Application Discontinuation
- 1980-04-03 AU AU57193/80A patent/AU536522B2/en not_active Ceased
- 1980-04-03 IE IE693/80A patent/IE49981B1/en unknown
- 1980-04-03 FI FI801078A patent/FI801078A/en not_active Application Discontinuation
- 1980-04-04 BE BE0/200139A patent/BE882669A/en not_active IP Right Cessation
- 1980-04-04 IL IL59772A patent/IL59772A/en unknown
- 1980-04-04 FR FR8007691A patent/FR2454099A1/en active Granted
- 1980-04-07 JP JP4475080A patent/JPS55143441A/en active Pending
- 1980-04-08 DK DK149980A patent/DK149980A/en not_active IP Right Cessation
- 1980-04-08 LU LU82345A patent/LU82345A1/en unknown
- 1980-04-09 NO NO801018A patent/NO801018L/en unknown
- 1980-04-09 NL NL8002094A patent/NL8002094A/en not_active Application Discontinuation
- 1980-04-09 ES ES490396A patent/ES8103380A1/en not_active Expired
- 1980-04-09 IT IT48370/80A patent/IT1143135B/en active
- 1980-04-10 CH CH277880A patent/CH644453A5/en not_active IP Right Cessation
- 1980-04-10 HU HU80871A patent/HU183122B/en unknown
- 1980-04-10 AR AR280624A patent/AR222700A1/en active
- 1980-04-10 DE DE19803013837 patent/DE3013837A1/en not_active Withdrawn
- 1980-04-10 AT AT0195780A patent/AT365343B/en not_active IP Right Cessation
- 1980-04-10 ZA ZA00802141A patent/ZA802141B/en unknown
- 1980-04-10 GR GR61652A patent/GR67692B/el unknown
- 1980-04-10 KR KR1019800001518A patent/KR830002502A/en unknown
- 1980-04-10 GB GB8011902A patent/GB2047712B/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
NO801018L (en) | 1980-10-13 |
FR2454099B1 (en) | 1984-01-27 |
IT1143135B (en) | 1986-10-22 |
HU183122B (en) | 1984-04-28 |
FR2454099A1 (en) | 1980-11-07 |
JPS55143441A (en) | 1980-11-08 |
KR830002502A (en) | 1983-05-30 |
AR222700A1 (en) | 1981-06-15 |
AU5719380A (en) | 1980-10-16 |
ZA802141B (en) | 1981-04-29 |
IL59772A (en) | 1983-05-15 |
ATA195780A (en) | 1981-05-15 |
NL8002094A (en) | 1980-10-14 |
AU536522B2 (en) | 1984-05-10 |
GB2047712B (en) | 1983-02-23 |
ES490396A0 (en) | 1981-02-16 |
BE882669A (en) | 1980-10-06 |
GB2047712A (en) | 1980-12-03 |
PH15637A (en) | 1983-03-11 |
CH644453A5 (en) | 1984-07-31 |
FI801078A (en) | 1980-10-11 |
LU82345A1 (en) | 1980-12-16 |
GR67692B (en) | 1981-09-07 |
AT365343B (en) | 1982-01-11 |
DE3013837A1 (en) | 1980-10-30 |
DK149980A (en) | 1980-10-11 |
IE49981B1 (en) | 1986-01-22 |
IL59772A0 (en) | 1980-06-30 |
SE8002602L (en) | 1980-12-09 |
IT8048370A0 (en) | 1980-04-09 |
ES8103380A1 (en) | 1981-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2090981A1 (en) | Immunological method for the determination of a haemoglobin derivative | |
KR880700668A (en) | Composition of amino acid chelates for delivery to specific biological tissue sites | |
SE8000469L (en) | TISSUE BINDING AND PROCEDURE FOR ITS MANUFACTURING AND USING THE BINDING AGENT | |
SE8501022D0 (en) | FORMAT CREATES AND PROCEDURES FOR ITS PREPARATION | |
DE69231473D1 (en) | IMMUNOCHEMICAL DETECTION OF END PRODUCTS OF ADVANCED GLYCOSYLATION IN VIVO | |
IE801902L (en) | Copolymer | |
CA2178752A1 (en) | N-Terminally Chemically Modified Protein Compositions and Methods | |
IE780912L (en) | A glycoprotain and process for the production thereof | |
Small Jr et al. | Peptide differences of rabbit γG-immunoglobulin light chains controlled by allelic genes | |
EP0247730A3 (en) | Antibodies, their preparation and use and products containing them | |
CA2140794A1 (en) | Assay for the determination of protein in a biological sample | |
ES8507692A1 (en) | Chromogenic tracers for use in an assay. | |
IE781198L (en) | Glycoprotein isolation | |
AU567747B2 (en) | Early detection of mammalian pregnancy | |
CA2112776A1 (en) | Process for inhibiting activity of endotoxin | |
IE39627L (en) | Hair and skin protection | |
DE3667061D1 (en) | New protein isolated from blood, process for preparing said protein, antibodies against said new protein, and pharmaceutical compositions containing said protein or said antibodies | |
EP0155104A3 (en) | Free analyte assay | |
IE800693L (en) | Cancer diagnostic test | |
York et al. | Interaction of fragments of fibrinogen with insolubilized fibrin monomers (activated fibrinogen) | |
EP0300381A3 (en) | Immunological detection of herbicides | |
JPS5569595A (en) | Novel substance having fibrinolytic activity, remedy for thrombotic embolic disease comprising it, and its preparation | |
Iwata et al. | Existence of two kinds of thiol protease inhibitors in rat serum | |
EP0373613A3 (en) | Pyridine-3-percarboxylic acid monopersulfate | |
ES8505915A1 (en) | Perfumery compounds and their preparation. |